Literature DB >> 1650149

The role of tumor necrosis factor-alpha in bone resorption of cholesteatoma.

S D Yan1, C C Huang.   

Abstract

Recent investigations have indicated that cytokines such as tumor necrosis factor-alpha (TNF-alpha) play a potential role in the bone resorption associated with inflammatory diseases. In this immunoperoxidase study, TNF-alpha was localized in mononuclear cells, macrophages, fibroblasts, osteoblasts, and osteoclasts adjacent to bone resorption areas in both human and experimental middle ear cholesteatomas. In vitro, TNF-alpha stimulated monocytes to form multinucleated cells that demonstrate tartrate-resistant acid phosphatase activity, a marker enzyme for osteoclasts. These multinucleated osteoclast-like cells induce resorption of devitalized bone. The extent of bone resorption was increased by the co-cultures of osteoblasts and osteoclasts in the presence of TNF-alpha, suggesting that cell to cell interaction plays a significant role in bone resorption. Moreover, TNF-alpha was capable of stimulating macrophages to produce acid phosphatase and collagenase, and osteoblasts to produce prostaglandin E2 and collagenase. These chemical mediators have been known to lead to bone resorption. Our findings suggest that TNF-alpha may play an important clinical role in the destructive process of cholesteatoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650149     DOI: 10.1016/0196-0709(91)90041-d

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  9 in total

1.  Platelet-derived growth factor in middle ear cholesteatoma.

Authors:  O Fujioka; C C Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

2.  Induction of cytokine production in cholesteatoma keratinocytes by extracellular high-mobility group box chromosomal protein 1 combined with DNA released by apoptotic cholesteatoma keratinocytes.

Authors:  Zhangcai Chi; Zhengmin Wang; Qiong Liang; Yaying Zhu; Qiang du
Journal:  Mol Cell Biochem       Date:  2014-11-23       Impact factor: 3.396

3.  Expression of pattern recognition receptors in cholesteatoma.

Authors:  Ho Yun Lee; Moon Suh Park; Jae Yong Byun; Young Il Kim; Seung Geun Yeo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-26       Impact factor: 2.503

4.  Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.

Authors:  Hans-J Welkoborsky; Roland S Jacob; Mike L Hinni
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-01       Impact factor: 2.503

5.  Increased Acquired Cholesteatoma Risk in Patients with Osteoporosis: A Retrospective Cohort Study.

Authors:  Tang-Chuan Wang; Che-Chen Lin; Chia-Der Lin; Hsiung-Kwang Chung; Ching-Yuang Wang; Ming-Hsui Tsai; Chia-Hung Kao
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

6.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

7.  Application of Propolis in Protecting Skeletal and Periodontal Health-A Systematic Review.

Authors:  Sophia Ogechi Ekeuku; Kok-Yong Chin
Journal:  Molecules       Date:  2021-05-25       Impact factor: 4.411

Review 8.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

Review 9.  The role of tumor necrosis factor-alpha (TNF-alpha) in bone resorption present in middle ear cholesteatoma.

Authors:  Rodrigo Faller Vitale; Fernando de Andrade Quintanilha Ribeiro
Journal:  Braz J Otorhinolaryngol       Date:  2007 Jan-Feb
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.